As the first vaccines for COVID-19 received emergency use authorization, the National Psoriasis Foundation (NPF) COVID-19 Task Force updated its guidance to include information on vaccines for those with psoriatic disease. That guidance states that, “Patients with psoriatic disease, who do not have contraindications to vaccination, should receive an mRNA-based COVID-19 vaccine as soon as it becomes available to them based on federal, state and local guidance.”
In early March, the guidance statements were once again updated to include the following: "The NPF Task Force recommends that individuals with psoriatic disease receive the first COVID-19 vaccine offered to them, as all three of the currently available vaccines are extremely effective at preventing serious COVID-19 outcomes like hospitalization and/or death."
While it is wonderful to be informed by this group of experts in the fields of dermatology, rheumatology, infectious disease and critical care, we know you also want to hear from people who are just like you.
We asked those with psoriatic disease in our community to share their experiences in receiving a COVID-19 vaccine, and thankfully, several of you were willing to share.
